|
|
 |
|
Call for review of AIDS vaccine San Francisco Chronicle As VaxGen Inc. prepares to unveil further analysis of its AIDS vaccine study at a scientific conference today, its reports of potential benefits to minority groups last month continue to draw both interest and scrutiny. A coalition of AIDS activist groups is calling for an independent review by the National Institutes of Health to assess the Brisbane company's claim that AIDSVAX holds the potential to protect blacks and other minority groups from HIV infection, though it failed for the mostly white study participants.
—Posted: March 31, 2003
More news headlines: This week | Last week | Search archive
|
|
|
